Related Experiment Videos
Protecting recognition sequences on DNA by a cleavage-deficient restriction endonuclease
1New England Biolabs, Beverly, MA 01915.
Biotechniques
|August 1, 1993
Summary
A novel mutant BamHI protein (E113K) acts as a biochemical tool to protect DNA sequences from enzymatic modification. This DNA binding-proficient, cleavage-deficient protein shields recognition sites from endonucleases, exonucleases, and methylases, enabling advanced DNA manipulation.
Area of Science:
- Molecular Biology
- Biochemistry
- Genetic Engineering
Background:
- Site-specific DNA modification is crucial for genetic engineering.
- Traditional methods face limitations in precise DNA sequence protection.
- Novel tools are needed to enhance control over DNA manipulation.
Purpose of the Study:
- To introduce a DNA binding-proficient and cleavage-deficient BamHI mutant protein (E113K) as a tool for DNA manipulation.
- To demonstrate the protective capabilities of the E113K mutant against various DNA-modifying enzymes.
- To expand the repertoire of in vitro DNA manipulation techniques.
Main Methods:
- Utilized a mutant BamHI protein (E113K) in in vitro experiments.
- Tested the E113K protein's ability to protect its recognition sequence (5'-GGATCC-3') from enzymatic action.
- Assessed protection against BamHI endonuclease, Sau3AI endonuclease, SmaI endonuclease, Dam methylase, and Bal31 exonuclease.
Main Results:
- The E113K protein successfully protected BamHI sites from cleavage by BamHI and Sau3AI endonucleases.
- Neighboring restriction sites (e.g., 5'-CCCGGG-3') were protected from SmaI digestion.
- Methylation of the BamHI site by Dam methylase was blocked.
- Bal31 exonuclease progression was inhibited at BamHI sites, enabling unidirectional deletions.
Conclusions:
- The E113K mutant protein serves as an effective biochemical tool for shielding specific DNA sequences.
- This method expands the available strategies for in vitro DNA manipulation, including protection from nucleases and methylases.
- The application of binding-proficient, cleavage-deficient mutant proteins offers enhanced control in molecular biology applications.